vendredi 24 juin 2016

Onco Actu du 24 juin 2016

5.10 Traitements - Essais

They’re going to CRISPR people. What could possibly go wrong? [STAT]

5.12 Immunothérapies

The Immuno-oncology Traffic Jam [In the Pipeline]

5.2.2 Pharma - Fusions & Acquisitions

Sanofi Said to Consider Adding Future Payments to Medivation Bid [Bloomberg]

5.2.3 Pharma - économie

Uncertainty for biotech as U.K. exits EU, Prime Minister to resign [FierceBiotech]

5.3 Traitements - FDA, EMA,...

EMA-ESMO workshop single-arm trials in cancer drug evaluation [EMA]

5.3.4 Traitements - AMM (FDA, EMA)

New cell-based therapy to support stem cell transplantation in patients with high-risk blood cancer [EMA]

5.4 Traitements - Economie

Why American Consumers Are Of Two Minds When It Comes To Drug Companies [Forbes]

6. Lutte contre les cancers

Moonshot Panel Moving Toward Final Report [National Cancer Institute]

Lung cancer surgery left her ‘leaking’ and near death. Belly fat saved her life [STAT]

6.1 Observation

How the mafia is causing cancer [Mosaic]

6.10 Politiques

A bill would would speed cheaper versions of pricey biologics to market [STAT]

The ‘Anti-Business’ President Who's Been Good for Business [Bloomberg]

6.11 Patients

The bond between cancer survivors is strong. That's why it's so hard when we lose each other [The Guardian]

6.6 Publications

Libraries May Have Gotten the Privacy Thing All Wrong [The Scholarly Kitchen]

6.7 DMP, Big Data & applis

Pharma, Data Veteran Stephen Friend Bites At Apple's Health Offer [Xconomy]